138 related articles for article (PubMed ID: 6132923)
1. Insulin-cholera toxin binding unit conjugate: a hybrid molecule with insulin biological activity and cholera toxin binding specificity.
Roth RA; Maddux B
J Cell Physiol; 1983 May; 115(2):151-8. PubMed ID: 6132923
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin diminishes tyrosine kinase activity of the insulin receptor.
Müller-Wieland D; Krone W
Biochem Int; 1992 Oct; 28(1):161-8. PubMed ID: 1445389
[TBL] [Abstract][Full Text] [Related]
3. The use of cholera toxin as a probe to study the organisation of ganglioside GM1 in membranes.
Critchley DR; Kellie S; Streuli CH; Patel B; Ansell S; Pierce E
Prog Clin Biol Res; 1982; 102 pt A():397-407. PubMed ID: 7167449
[No Abstract] [Full Text] [Related]
4. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
Lycke NY
J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421
[TBL] [Abstract][Full Text] [Related]
5. The binding potential between the cholera toxin B-oligomer and its receptor.
Cai XE; Yang J
Biochemistry; 2003 Apr; 42(14):4028-34. PubMed ID: 12680755
[TBL] [Abstract][Full Text] [Related]
6. Insulin-ricin B chain conjugate has enhanced biological activity in insulin-insensitive cells.
Roth RA; Iwamoto Y; Maddux B; Goldfine ID
Endocrinology; 1983 Jun; 112(6):2193-9. PubMed ID: 6343061
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cholera toxin activation of the adenylate cyclase system in intact HeLa cells.
Lin MC; Taniuchi M
J Cyclic Nucleotide Res; 1980; 6(5):359-67. PubMed ID: 7217459
[TBL] [Abstract][Full Text] [Related]
8. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
[TBL] [Abstract][Full Text] [Related]
9. Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure.
McCann JA; Mertz JA; Czworkowski J; Picking WD
Biochemistry; 1997 Jul; 36(30):9169-78. PubMed ID: 9230049
[TBL] [Abstract][Full Text] [Related]
10. Method for selective labeling of cholera toxin binding region.
Battistini A; Gallina A; Tomasi M
Ann Ist Super Sanita; 1983; 19(2-3):379-83. PubMed ID: 6598297
[No Abstract] [Full Text] [Related]
11. SR4987 and L1210 cell lines: two models in which cholera toxin susceptibility does not correlate with cAMP accumulation and ganglioside content.
Pessina A; Mineo E; Neri MG; Piccirillo M; Valore L; Giulani A
Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):933-40. PubMed ID: 9763197
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of cholera toxin on in vitro growth of human lung cancer cell lines.
Kiura K; Watarai S; Shibayama T; Ohnoshi T; Kimura I; Yasuda T
Anticancer Drug Des; 1993 Dec; 8(6):417-28. PubMed ID: 8286010
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity.
Critchley DR; Streuli CH; Kellie S; Ansell S; Patel B
Biochem J; 1982 Apr; 204(1):209-19. PubMed ID: 7052064
[TBL] [Abstract][Full Text] [Related]
14. Insulin action in cultured HTC and H35 rat hepatoma cells: receptor binding and hormone sensitivity.
Iwamoto Y; Wong KY; Goldfine ID
Endocrinology; 1981 Jan; 108(1):44-51. PubMed ID: 6161802
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit.
Mertz JA; McCann JA; Picking WD
Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604
[TBL] [Abstract][Full Text] [Related]
16. Surface immobilized cholera toxin B subunit (CTB) facilitates vesicle docking, trafficking and exocytosis.
Soo JC; Zhang J; He Q; Agarwal S; Li H; Zhang H; Chen P
Integr Biol (Camb); 2010 Jun; 2(5-6):250-7. PubMed ID: 20535419
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent derivatives of ganglioside GM1 function as receptors for cholera toxin.
Spiegel S
Biochemistry; 1985 Oct; 24(21):5947-52. PubMed ID: 3002428
[TBL] [Abstract][Full Text] [Related]
18. Fluorescently labeled liposomes for monitoring cholera toxin binding to epithelial cells.
Edwards KA; Duan F; Baeumner AJ; March JC
Anal Biochem; 2008 Sep; 380(1):59-67. PubMed ID: 18549803
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cholera toxin-ganglioside interactions by flow cytometry.
Lauer S; Goldstein B; Nolan RL; Nolan JP
Biochemistry; 2002 Feb; 41(6):1742-51. PubMed ID: 11827518
[TBL] [Abstract][Full Text] [Related]
20. Destruction of cholera toxin receptor on HeLa cell membrane using microbial endoglycoceramidase.
Yamamoto K; Nagano T; Kumagai H; Okamoto Y; Otani S
Arch Biochem Biophys; 1996 Apr; 328(1):51-6. PubMed ID: 8638937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
